[Ju]
Wonkyu “Daniel” Ju, PhD, Professor in the Viterbi Family Department of Ophthalmology, and the Shiley Eye Institute (SEI), was awarded $1,530,352 in UG3 grant funding by the National Institutes of Health (NIH) to support the development of novel gene therapy to reduce retinal neuroinflammation and provide effective neuroprotection to glaucoma patients.
Glaucoma remains a leading cause of global blindness by damaging the nerve in the back of the eye called the optic nerve. The symptoms start gradually so that they may not even be noticed. There is no cure for glaucoma, but early treatment can often stop the damage and protect sight. Therapies include eye drops, laser treatment or surgery.
Emerging evidence suggests that glia-neuroinflammation is a critical element that leads to retinal ganglion cell (optic nerve cell) death and optic nerve degeneration in the development of glaucoma. According to Ju, “These studies will develop a novel gene therapy to reduce retinal neuroinflammation and mitochondrial dysfunction as well as provide effective neuroprotection to glaucoma patients.”
If successful, IND-enabling studies will be conducted at UC San Diego in order to obtain FDA approval for the first-in-human trial. Co-Investigator Robert N. Weinreb, MD, Distinguished Professor and Chair of the Department of Ophthalmology, notes that “Our department receiving this prestigious grant marks a groundbreaking moment as it’s the first time a glaucoma genetic therapeutic approach, spanning preclinical and clinical trials, has been awarded NIH funding.”
The project is a collaborative endeavor that draws upon the collective strengths and resources of UC San Diego, RAFT Pharmaceuticals, and the NIH Blueprint Neurotherapeutics Network – Biologic.
The only way to find out if you have glaucoma is to get a comprehensive dilated eye exam by an eyecare professional. To make an appointment with an SEI glaucoma specialist, please call 858-534-6290.
For information at SEI, please contact Karen Anisko Ryan at [email protected] .
(858) 534-6290
The information contained in this online site is intended to provide accurate and helpful health information for the general public. It is made available with the understanding that the author and publisher are not engaged in rendering medical, health, psychological, or any other kind of personal professional services on this site. The information should not be considered complete and does not cover all diseases, ailments, physical conditions or their treatment. It should not be used in place of a call or visit to a medical, health or other competent professional, who should be consulted before adopting any of the suggestions in this site or drawing inferences from it.
The information about drugs contained on this site is general in nature. It does not cover all possible uses, actions, precautions, side effects, or interactions of the medicines mentioned, nor is the information intended as medical advice for individual problems or for making an evaluation as to the risks and benefits of taking a particular drug.
The operator(s) of this site, and the publisher, specifically disclaim all responsibility for any liability, loss or risk, personal or otherwise, which is incurred as a consequence, directly or indirectly, of the use and application of any of the material on this site.
Click Here To Accept